Multiplex Assay Market to Reach USD 153 Million by 2030, Growing at a CAGR of 6%

Multiplex Assay Market to Reach USD 153 Million by 2030, Growing at a CAGR of 6%

 

According to Next Move Strategy Consulting, the global Multiplex Assay Market, is projected to grow at a compound annual growth rate (CAGR) of 6%, reaching an estimated USD 153 million by 2030. This growth is driven by the increasing demand for efficient, high-throughput testing solutions across various industries, including healthcare, pharmaceuticals, and research.

Download Free Sample: https://www.nextmsc.com/multiplex-assay-market/request-sample

Market Overview

Multiplex assay tests are designed to simultaneously measure multiple analytes in a single experiment, offering high precision and efficiency. These tests amplify multiple targets using Polymerase Chain Reaction (PCR) technology, allowing for the analysis of proteins, cytokines, biomolecules, and other analytes in minimal time and with small sample quantities. The applications for multiplex assays are vast, with uses in mutation analysis, DNA and RNA detection, pathogen detection, forensic studies, and clinical diagnostics. Moreover, the rise in companion diagnostics adoption further fuels the demand for these advanced testing methods.

Market Dynamics and Trends

The multiplex assay market is witnessing significant growth, spurred by the benefits these tests offer, such as requiring minimal substrates, delivering faster results, reducing labor costs, and improving operational efficiency. However, the high cost of equipment and stringent regulatory standards pose challenges to market growth.

On the positive side, increasing investments in research and development (R&D) activities, along with advancements in healthcare infrastructure and medical laboratories, are expected to further drive the market forward.

Inquire Before Buying: https://www.nextmsc.com/multiplex-assay-market/inquire-before-buying

Market Segmentation and Scope

The global multiplex assay market is segmented based on product type, technology, application, end-user, and geography:

  • By Product: Reagents & consumables, instruments & accessories, and software & services.
  • By Type: Nucleic acid-based multiplex assays, protein-based multiplex assays, and others.
  • By Technology: Multiplex PCR, multiplex protein microarray, and others.
  • By Application: Companion diagnostics, research & development, and clinical diagnostics.
  • By End-User: Hospitals, clinical laboratories, research institutes, and pharmaceutical & biotechnological companies.

Geographical Analysis

North America is expected to maintain a dominant share of the multiplex assay market throughout the forecast period, owing to advanced healthcare infrastructure, high prevalence of chronic disorders, and significant technological advancements. Meanwhile, the Asia-Pacific region is projected to witness significant growth due to the rising adoption of companion diagnostics, increased demand for advanced healthcare technologies, and new product launches.

Competitive Landscape

The multiplex assay market is highly competitive, with key players such as Thermo Fisher Scientific Inc., Luminex Corporation, Bio-Rad Laboratories Inc., Illumina Inc., Becton, Dickinson and Company, QIAGEN N.V., Seegene Inc., Abcam PLC, Randox Laboratories Ltd., and Meso Scale Diagnostics LLC leading the charge.

Recent innovations by these companies are making significant contributions to global health. For instance, in April 2020, Bio-Rad Laboratories received Emergency Use Authorization from the U.S. FDA for its Droplet Digital PCR SARS-CoV-2 Test Kit, offering enhanced sensitivity for early-stage detection of COVID-19. Thermo Fisher Scientific also launched five new Thermo Scientific SureTect PCR Assay test kits, delivering results within 24 hours for food safety applications.

Conclusion

The global multiplex assay market is on an upward trajectory, driven by technological advancements, increasing applications in clinical diagnostics, and expanding research activities. Despite challenges such as high equipment costs and regulatory hurdles, the demand for efficient and accurate diagnostic tools continues to accelerate, promising strong growth for the market in the coming decade.

Also, Browse Related Reports:   

For more information, please contact:

Next Move Strategy Consulting

E-Mail: info@nextmsc.com

Direct: +1-217-650-7991

Website: www.nextmsc.com

Follow Us: LinkedIn | Twitter | Facebook | Instagram | YouTube

About Next Move Strategy Consulting:

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

Back to blog